Trial Profile
Phase II Trial With Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin (PLD) and Carboplatin in Malignant Gynecologic Tumour's.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Doxorubicin liposomal (Primary)
- Indications Cervical cancer; Endometrial cancer; Gynaecological cancer; Ovarian cancer; Uterine cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2006 New trial record.